Literature DB >> 11859074

Phosphatidylinositol 3-kinase/Akt signaling is neither required for hypoxic stabilization of HIF-1 alpha nor sufficient for HIF-1-dependent target gene transcription.

Andrew M Arsham1, David R Plas, Craig B Thompson, M Celeste Simon.   

Abstract

The serine/threonine kinase Akt/PKB and the oxygen-responsive transcription factor HIF-1 share the ability to induce such processes as angiogenesis, glucose uptake, and glycolysis. Akt activity and HIF-1 are both essential for development and implicated in tumor growth. Upon activation by products of phosphatidylinositol 3-kinase (PI3K), Akt phosphorylates downstream targets that stimulate growth and inhibit apoptosis. Previous reports suggest that Akt may achieve its effects on angiogenesis and glucose metabolism by stimulating HIF-1 activity. We report here that, whereas serum stimulation can induce a slight accumulation of HIF-1 alpha protein in a PI3K/Akt pathway-dependent fashion, hypoxia induces much higher levels of HIF-1 alpha protein and HIF-1 DNA binding activity independently of PI3K and mTOR activity. In addition, we find the effects of constitutively active Akt on HIF-1 activity are cell-type specific. High levels of Akt signaling can modestly increase HIF-1 alpha protein, but this increase does not affect HIF-1 target gene expression. Therefore, the PI3K/Akt pathway is not necessary for hypoxic induction of HIF-1 subunits or activity, and constitutively active Akt is not itself sufficient to induce HIF-1 activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11859074     DOI: 10.1074/jbc.M111162200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

1.  Signalling of DNA damage and cytokines across cell barriers exposed to nanoparticles depends on barrier thickness.

Authors:  A Sood; S Salih; D Roh; L Lacharme-Lora; M Parry; B Hardiman; R Keehan; R Grummer; E Winterhager; P J Gokhale; P W Andrews; C Abbott; K Forbes; M Westwood; J D Aplin; E Ingham; I Papageorgiou; M Berry; J Liu; A D Dick; R J Garland; N Williams; R Singh; A K Simon; M Lewis; J Ham; L Roger; D M Baird; L A Crompton; M A Caldwell; H Swalwell; M Birch-Machin; G Lopez-Castejon; A Randall; H Lin; M-S Suleiman; W H Evans; R Newson; C P Case
Journal:  Nat Nanotechnol       Date:  2011-11-06       Impact factor: 39.213

2.  Association of progressive structural changes in the bronchial epithelium with subepithelial fibrous remodeling: a potential role for hypoxia.

Authors:  Vasiliy V Polosukhin; William E Lawson; Aaron P Milstone; Svetlana M Egunova; Andrey G Kulipanov; Sergey G Tchuvakin; Pierre P Massion; Timothy S Blackwell
Journal:  Virchows Arch       Date:  2007-08-03       Impact factor: 4.064

3.  Pyrithione-zinc Prevents UVB-induced Epidermal Hyperplasia by Inducing HIF-1alpha.

Authors:  Young-Suk Cho; Kyung-Hoon Lee; Jong-Wan Park
Journal:  Korean J Physiol Pharmacol       Date:  2010-04-30       Impact factor: 2.016

4.  Increased glucose metabolism by FDG-PET correlates with reduced tumor angiogenesis in oral squamous cell carcinoma.

Authors:  Mikiko Nakamura; Yoshimasa Kitagawa; Yutaka Yamazaki; Hironobu Hata; Motoko Kotsuji; Yasuhisa Fujibayashi; Hidehiko Okazawa; Yoshiharu Yonekura; Kazuo Sano
Journal:  Odontology       Date:  2011-05-13       Impact factor: 2.634

5.  Noninvasive detection of target modulation following phosphatidylinositol 3-kinase inhibition using hyperpolarized 13C magnetic resonance spectroscopy.

Authors:  Christopher S Ward; Humsa S Venkatesh; Myriam M Chaumeil; Alissa H Brandes; Mark Vancriekinge; Hagit Dafni; Subramaniam Sukumar; Sarah J Nelson; Daniel B Vigneron; John Kurhanewicz; C David James; Daphne A Haas-Kogan; Sabrina M Ronen
Journal:  Cancer Res       Date:  2010-02-09       Impact factor: 12.701

6.  Validation of an engineered cell model for in vitro and in vivo HIF-1α evaluation by different imaging modalities.

Authors:  A Lo Dico; S Valtorta; C Martelli; S Belloli; U Gianelli; D Tosi; S Bosari; A Degrassi; M Russo; I Raccagni; G Lucignani; R M Moresco; L Ottobrini
Journal:  Mol Imaging Biol       Date:  2014-04       Impact factor: 3.488

7.  Activation of hypoxia-inducible factor 1 in human T-cell leukaemia virus type 1-infected cell lines and primary adult T-cell leukaemia cells.

Authors:  Mariko Tomita; Gregg L Semenza; Canine Michiels; Takehiro Matsuda; Jun-Nosuke Uchihara; Taeko Okudaira; Yuetsu Tanaka; Naoya Taira; Kazuiku Ohshiro; Naoki Mori
Journal:  Biochem J       Date:  2007-09-01       Impact factor: 3.857

8.  The N-terminal transactivation domain confers target gene specificity of hypoxia-inducible factors HIF-1alpha and HIF-2alpha.

Authors:  Cheng-Jun Hu; Aneesa Sataur; Liyi Wang; Hongqing Chen; M Celeste Simon
Journal:  Mol Biol Cell       Date:  2007-09-05       Impact factor: 4.138

9.  Loss of pVHL is sufficient to cause HIF dysregulation in primary cells but does not promote tumor growth.

Authors:  Fiona A Mack; W Kimryn Rathmell; Andrew M Arsham; James Gnarra; Brian Keith; M Celeste Simon
Journal:  Cancer Cell       Date:  2003-01       Impact factor: 31.743

10.  Molecular mechanisms of HIF-1alpha modulation induced by oxygen tension and BMP2 in glioblastoma derived cells.

Authors:  Francesca Pistollato; Elena Rampazzo; Sara Abbadi; Alessandro Della Puppa; Renato Scienza; Domenico D'Avella; Luca Denaro; Geertruy Te Kronnie; David M Panchision; Giuseppe Basso
Journal:  PLoS One       Date:  2009-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.